Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (321-330 of 470) with videos related to

Pageof 47
Sort By:
Epilepsia|November 1, 1985
Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunctionR G Dickinson, R M Kluck, W D Hooper, et al.
The Biochemical Journal|February 12, 2008
N-glycosylation analysis of the human Tweety family of putative chloride ion channels supports a penta-spanning membrane arrangement: impact of N-glycosylation on cellular processing of Tweety homologue 2 (TTYH2)Yaowu He, Andrew J Ramsay, Melanie L Hunt, et al.
BMC Research Notes|November 23, 2012
Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangementsSean D Hooper, Xiang Jiao, Elisabeth Sundström, et al.
The Prostate|February 15, 2022
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory productsCharles N Pagel, Pamu K Kularathna, Reza Sanaei, et al.
The Medical Journal of Australia|February 26, 1972
Blood phenytoin concentrations produced by ingestion of three different phenytoin preparationsD B Appleton, M J Eadie, W D Hooper, et al.
British Journal of Clinical Pharmacology|May 3, 2000
Apparent autoinduction of valproate beta-oxidation in humansD B McLaughlin, J A Andrews, W D Hooper, et al.
Cancer Research|December 4, 2002
A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reactionAndries Zijlstra, Rebecca Mellor, Giano Panzarella, et al.
The Journal of Biological Chemistry|March 1, 2008
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progressionAndrew J Ramsay, Ying Dong, Melanie L Hunt, et al.
Endocrine|February 1, 2015
Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapyAnnie-Claude M Lassemillante, Suhail A R Doi, John D Hooper, et al.
Plos One|July 30, 2011
Structural alterations from multiple displacement amplification of a human genome revealed by mate-pair sequencingXiang Jiao, Magnus Rosenlund, Sean D Hooper, et al.
Pageof 47

Showing results (321-330 of 470) with videos related to

Sort By:
Pageof 47
Epilepsia|November 1, 1985
Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunctionR G Dickinson, R M Kluck, W D Hooper, et al.
The Biochemical Journal|February 12, 2008
N-glycosylation analysis of the human Tweety family of putative chloride ion channels supports a penta-spanning membrane arrangement: impact of N-glycosylation on cellular processing of Tweety homologue 2 (TTYH2)Yaowu He, Andrew J Ramsay, Melanie L Hunt, et al.
BMC Research Notes|November 23, 2012
Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangementsSean D Hooper, Xiang Jiao, Elisabeth Sundström, et al.
The Prostate|February 15, 2022
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory productsCharles N Pagel, Pamu K Kularathna, Reza Sanaei, et al.
The Medical Journal of Australia|February 26, 1972
Blood phenytoin concentrations produced by ingestion of three different phenytoin preparationsD B Appleton, M J Eadie, W D Hooper, et al.
British Journal of Clinical Pharmacology|May 3, 2000
Apparent autoinduction of valproate beta-oxidation in humansD B McLaughlin, J A Andrews, W D Hooper, et al.
Cancer Research|December 4, 2002
A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reactionAndries Zijlstra, Rebecca Mellor, Giano Panzarella, et al.
The Journal of Biological Chemistry|March 1, 2008
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progressionAndrew J Ramsay, Ying Dong, Melanie L Hunt, et al.
Endocrine|February 1, 2015
Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapyAnnie-Claude M Lassemillante, Suhail A R Doi, John D Hooper, et al.
Plos One|July 30, 2011
Structural alterations from multiple displacement amplification of a human genome revealed by mate-pair sequencingXiang Jiao, Magnus Rosenlund, Sean D Hooper, et al.
Pageof 47